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Tephrosia purpurea, (Syn: Galega purpurea,
Linn.; Family: Fabaceae) is locally known as Bansa
(Punjabi), Sarphunka (Hindi) and Jangli kulthi
(Sindhi). It grows wild throughout Indo-Pak-Bangla
Desh subcontinent on hard and stony grounds (1-3).
It is branched and sub-erect herbaceous perennial
plant, about 30-60 cm in height with spreading
branches; leaves imparipinnate, leaflets 11-21, nar-
row, oblanceloate; flowers red or purple in extra
axillary racemes; fruits are slightly curved pods, 3-4
cm long, seeds 5-10 per pod, smooth, shiny grey in
coloration. The plants are propagated through seeds
(4, 5).
Phytochemical investigations revealed the
presence of β-sitosterol, quercetin, lupeol, rutin, del-
phinidine chloride, cyaniding chloride, isolon-
chocarpin, lanceolatins A and B, pongamol,
karangin, kangone, 5,7-dimethoxy-8-flavanone, 2-
methoxy-3,9-dihydroxycoumestone, flevichap-
parins B and C, methyl karanjic acid and purpurin
among the plant constituents (6, 7).
Resistance to the present compounds against
management of different diseases has lead to search
for the new candidates (8, 9). Tephrosia purpurea is
reputed to possess diuretic, antipyretic, anti-inflam-
matory, anti-ulcer, anti-asthmatic, anti-leprosy and
anthelmintic properties (10, 11). The aim of this
study was to evaluate spasmolytic, bronchodilator
and vasorelaxant activity of methanolic extract of
Tephrosia purpurea.
MATERIALS AND METHODS
Plant material
Whole plant of Tephrosia purpurea was collect-
ed from the local herbal market of Multan, Pakistan.
These plant material was identified/authenticated by
the kind cooperation of an expert taxonomist (Prof.
Dr. Altaf Ahmad Dasti) at the Institute of Pure and
Applied Biology, Bahauddin Zakariya University,
Multan and voucher specimen was deposited in the
herbarium.
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Preparation of crude extract
The herbal material was shade dried and ren-
dered free of any dust particles or adulterated mate-
rials by manual picking. It was subsequently grind-
ed to coarse powder by an electrically driven grind-
ing machine. About 500 g of the coarsely grinded
powder materials was soaked in 80% aqueous
methanol for eight days with occasional shaking
(11). The material was passed through double lay-
ered muslin cloth to get rid of organic debris and the
fluid portion was filtered through Whatman grade 1
filter paper. The collected filtrate was subsequently
concentrated to thick semi solid mass at 37OC on a
rotary evaporator (R210, Buchi, Switzerland) under
reduced pressure and was dried further through
freeze drying and transferred to final containers to
kept in refrigerator (-4OC). The approximate yield
was 4.0%. Different dilutions of the crude extract
were made fresh on the day of experiment. 
Chemicals
Acetylcholine chloride, atropine sulfate, carba-
chol (CCh), histamine, isoprenaline, pyrillamine,
potassium chloride, verapamil hydrochloride and
phenylephrine (PE), magnesium chloride, ethylene-
diaminetetraacetic acid (EDTA) were purchased
from Sigma Chemicals Co. St Louis, MO, USA.
Calcium chloride, glucose, magnesium sulfate,
potassium dihydrogen phosphate, sodium bicarbon-
ate, sodium dihydrogen phosphate, and methanol
were obtained from Merck, Darmstadt, Germany.
Ammonium hydroxide, sodium chloride, and sodi-
um hydroxide were purchased from BDH
Laboratory supplies, Poole, England.
The chemicals used in these experiments were
of the highest purity and reagent analytical research
grade. Stock solutions and subsequent dilutions
were made fresh in distilled water on the day of
experiment. The drugs were solublized in vehicles
which were without any effect on tissue contractili-
ty in control experiments. 
Animals and housing conditions 
Animals (ο↑ /ο+) used in this study were rabbits
(1.0-1.8 kg), guinea-pigs (500-600 g), Bulb-c mice
(20-30 g) and Sprague-Dawley rats (200-300 g).
They were housed under controlled environmental
condition (23-25OC) at the animal house of The Aga
Khan University, Karachi. The animals were given
standard diet and tap water ad libitum. The animals
were deprived of food 24 h prior to the experiments
but were given free access to water. Rabbits were
sacrificed following a blow on back of head, while
rats and guinea-pigs were killed by cervical disloca-
tion to be used for in vitro studies, whereas mice
were used for the in vivo studies. All the experi-
ments performed complied with the rulings of
Institute of Laboratory Animal Resources,
Commission on Life Sciences (NRC, 1996),
approved by the Ethical Committee of The Aga
Khan University, Karachi.
Preliminary phytochemical studies
The crude methanolic extract of Tephrosia pur-
purea (Tp.Cr) was subjected to qualitative phyto-
chemical analysis for the presence of alkaloids,
saponins, anthraquinones, coumarins, sterols, ter-
penes, flavonoids and phenols as described by Tona
et al. (12).
The crude plant extracts were subjected to pre-
liminary phytochemical screening for qualitative
detection of the presence of some constituents of
particular phytochemical classes (13). The saponin
presence was detected by the froth formation on vig-
orous shaking of the aqueous extract solution.
Development of blue green or dark green coloration
on mixing of aqueous FeCl3 with extract solution
indicated the presence of phenols and tannins. The
coumarins as plant constituents were detected on
emission of fluorescence in ultra-violet light from
pieces of filter paper which were exposed to the
vapors emerging from boiling aqueous solution of
plant extract, subsequent to treatment with NaOH.
The alkaloid presence was noted by the appearance
of yellowish brown coloration on mixing of
Dragendorffís reagent (solution of potassium bis-
muth iodide) with HCl treated aqueous plant extract
solution. The appearance of pink, violet or red col-
oration on exposure to NH4OH of the mixture of
benzene with aqueous solution of plant extract
already acidified with 1% HCl was taken as the
presence of anthraquinones among the plant con-
stituents.
In vitro experiments
Isolated tissues experiments were performed as
described by Gilani et al. (13).
Isolated rabbit jejunum preparations
Plant extract was tested on isolated rabbit
jejunum preparations for possible presence of spas-
mogenic and/or spasmolytic activity. Isolated rabbit
jejunum segments of approximately 2 cm in length
were suspended in isolated tissue baths containing
Tyrodeís solution, at 37OC, aerated with carbogen
(95% O2 and 5% CO2). The composition of the
Tyrodeís solution (mM) was: KCl (2.68), NaCl
(136.9), MgCl2 (1.05), NaHCO3 (11.90), NaH2PO4
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(0.42), CaCl2 (1.8) and glucose (5.55). A preload of
1 g was applied and intestinal responses were
recorded isotonically using Bioscience transducers
coupled to Harvard Student Oscillograph. The tis-
sues were allowed to equilibrate for at least 30 min
prior to the addition of any drug. Isolated rabbit
jejunum preparations exhibit spontaneous rhythmic
contractions and allow testing of the antispasmodic
(relaxant) effect without application of an agonist.
The observed response of the test material was
quantified by the application of doses in a cumula-
tive fashion. The relaxant effects on the part of test
substance were taken as the percent change in spon-
taneous contractions of the preparation recorded
immediately before the addition of test substances.
The possible mechanism of the relaxant activi-
ty of the test material was investigated through the
relaxation of the observed sustained spasmodic con-
tractions following exposure to high concentration
of K+ (80 mM) (14). The test material was applied in
a cumulative manner to the sustained contractions to
achieve concentration-dependent inhibitory
responses. The observed relaxant effect of the test
material on K+ (80 mM)-induced contraction was
expressed as percent of the control contractile
response.
Calcium channel blocking effect of the test sub-
stance was confirmed by the method described pre-
viously by Gilani et al. (15, 16). The isolated rabbit
jejunum preparation was allowed to stabilize in nor-
mal Tyrodeís solution, which was subsequently
replaced for 30 min with Ca2+-free Tyrodeís solution
to which EDTA (0.1 mM) was added in order to
remove calcium from the tissue. This bath solution
was further replaced with K+-rich and Ca2+-free
Tyrodeís solution, having the following composition
(mM): KCl (50), NaCl (91.04), MgCl2 (1.05),
NaHCO3 (11.90), NaH2PO4 (0.42), glucose (5.55)
and EDTA (0.1). Subsequent to an incubation period
of 30 min, cumulative Ca2+ concentrations were
applied to the tissue bath to obtain control calcium
dose-response curves (DRCs). On achievement of
the super-imposable control calcium dose-response
curves (usually after two cycles), the tissues were
then washed and allowed to equilibrate with the plant
extract for 1 h and then the concentration response
curves of Ca2+ were recorded and compared to the
control curves. The dose-response curves (DRCs) of
Ca2+ were recorded in the presence of different con-
centrations of the plant extract in tissue bath.
Isolated guinea-pig ileum preparations
The ileum was dissected and kept in Tyrodeís
solution having composition as described earlier.
Since isolated guinea pig ileum behave as a quies-
cent preparation, is considered more suitable for
spasmogenic activity. The segments, about 2 cm
long, were suspended individually in isolated tissue
bath, filled with Tyrodeís solution, aerated with car-
bogen and maintained at 37OC. Different concentra-
tions of plant material were applied and tissue was
washed every time The isotonic contractions were
recorded with Powerlab Data Acquisition System
(AD Instruments, Sydney, Australia) attached to a
computer installed with labchart software (version
6). Each tissue was allowed to equilibrate for at least
30 min before the addition of any drug. After tissue
equilibration, each tissue preparation was repeated-
ly treated with sub-maximal concentrations (0.3
µM) of Ach at 3 min intervals until constant
responses were recorded. Different concentrations
of plant material were applied and tissue was
washed every time after getting spasmogenic
response of each concentration of crude extract and
doses were added as bolus dose. Responses were
calculated by taking the response of acetylcholine
before each bolus dose of plant extract as a control
and acetylcholine maximum (Ach max.) response if
required, was used as control. Then tissue was
washed and procedure was repeated again with sub
maximal dose of acetylcholine.
Isolated rabbit and guinea pig tracheal prepara-
tions
Rabbit and guinea pig tracheas were dissected
out and kept in Krebs solution having the following
composition (mM): NaCl (118.2), NaHCO3 (25.0),
CaCl2 (2.5), KCl (4.7), KH2PO4 (1.3), MgSO4 (1.2)
and glucose (11.7). The trachea was cleaned free
from the adhering fatty tissues and rings of 2-3 mm
width containing 2-3 cartilages were prepared.
Each ring was opened by a longitudinal incision on
the ventral side opposite to the smooth muscles
layer to form a strip with smooth muscles layer in
middle and cartilages on both sides. These tracheal
preparations were mounted in 20 mL organ bath
containing Krebs solution being maintained at
37OC and aerated with carbogen. A preload tension
of 1 g was applied and tissue preparations were
allowed to be equilibrated for 1 h prior to any chal-
lenge by the drug. Tissue preparations were stabi-
lized by repeated applications of carbachol (1 µM)
until constant responses were recorded. The carba-
chol (1 µM)- and high K+ (80 mM)-induced sus-
tained contractions were subsequently used for
testing of different doses of the test material in a
cumulative fashion. The isometric responses were
recorded through Power lab data acquisition sys-
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tem (AD Instruments, Sydney, Australia) attached
to a computer installed with lab chart software
(Version 6). The standard drugs with Ca2+ channel
blocking effect (verapamil and papaverine) were
tested on high K+ (80 mM)- and carbachol-induced
spastic contractions in order to confirm the possi-
ble mechanism of action (17).
Isolated rabbit aorta preparations
The effect of Tp.Cr on systemic vascular resist-
ance was assessed on isolated rabbit aorta prepara-
tions, rabbits of either sex were sacrificed by a blow
on the back of head and descending thoracic aorta
was dissected out and kept in the normal Krebs solu-
tion having composition as described earlier. It was
then cut into rings of about 2-3 mm width and each
ring was mounted in a tissue bath containing Krebs
solution. Temperature was maintained at 37OC and
tissue was continuously aerated with carbogen. A
pre-load of 2 g was applied to each preparation and
allowed to equilibrate for a period of 1 h. After equi-
libration, tissue was stabilized by repeated exposure
to K+ (80 mM) or phenylephrine (1 µM) depending
upon the protocol of the experiment. The vasorelax-
ant/vasoconstrictive effects of the test substances
were studied by addition in tissue organ baths con-
taining pre-stabilized tissue in a cumulative manner.
Changes in isometric tension of aortic rings were
obtained via force-displacement transducer (Model
FORT100, WPI, USA) coupled to a transbridge
(model TBM4M, WPI, USA) and PowerLab data
acquisition system (AD Instruments, Sydney,
Australia) and computer running Lab Chart software
(version 6).
Statistical analysis
The data were expressed as the mean ± stan-
dard error of the mean (SEM, n = number of ani-
mals) and the median inhibitory concentrations
(IC50) with 95% confidence intervals (CI). The sta-
tistics applied Studentís t-test except in case of cas-
tor oil induced diarrhea where χ2-test was used and
p < 0.05 was taken as significant difference.
Concentration-response curves (CRCs) were ana-
lyzed by non-linear regression using Graph Pad pro-
gram (Graph PAD, San Diego, CA, USA).
Figure 1. (a) Control, (b) effect of Tp.Cr and (c) effect of verapamil on spontaneous contractions in isolated rabbit jejunum preparations
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RESULTS
Phytochemical studies
Preliminary phytochemical studies on
Tephrosia purpurea were undertaken to reveal the
presence of different secondary metabolites of the
plant. The outcome of the study indicated the pres-
ence of tannins, saponin, flavonoids and phenols
among the methanol soluble extractable constituents
of Tephrosia purpurea.
Effect of crude extract of Tephrosia purpurea on
rabbit jejunum
The crude extract of Tephrosia purpurea
exhibited a concentration-dependent inhibitory
effect on spontaneous contractions of isolated rab-
bit jejunum preparations. The inhibitory effect was
observed in the dose range of (0.003-3.0 mg/mL)
in cumulative manner and EC50 value was found to
be of 0.658 mg/mL (95% CI; 0.5632-0.7690) (Fig.
1a). The spontaneous contractions were revived
following washing the isolated jejunum prepara-
tion with Tyrodeís solution and addition of
atropine (0.1 µM) did not show any effect on the
relaxant activity of Tp.Cr. Similarly, verapamil, a
standard calcium channel blocker, relaxed the
spontaneous contractions of isolated rabbit
jejunum preparations in concentration dependent
manner in the tissue bath concentration range of
(0.003-1.0 µM), with EC50 value of 0.208 mg/mL
(95% CI; 0.1863-0.2337) (Fig. 1b). Moreover,
Tp.Cr also shifted the concentration-response
curves (CRC) of Ca2+ rightward in a manner simi-
lar to verapamil (Fig. 5a,b).
Figure 2. Effects of (a) Tp.Cr and (b) verapamil on spontaneous
and K+ (80 mM)-induced contractions in isolated rabbit jejunum
preparations. Values are expressed as the mean ± SEM, n = 5
Figure 3. Effects of (a) Tp.Cr and (b) verapamil on K+ (80 mM)-induced contractions in isolated rabbit jejunum preparations
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Figure 4. The inhibitory effect of (a) Tp.Cr and (b) verapamil on
carbachol (1 µM) and K+ (80 mM)-induced contraction in isolated
rabbit tracheal preparations in a concentration dependent manner.
Values shown are the mean ± SEM, n = 5
Figure 5. Effect of (a) Tp.Cr and (b) verapamil on concentration
response curves of Ca2+ in isolated rabbit jejunum preparations.
Values shown are the mean ± SEM, n = 5
Figure 6. Effect of Tp.Cr on (a) carbachol (1 µM) and (b) K+ (80 mM)-induced contractions in isolated rabbit tracheal preparations
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Effect of Tp.Cr on K+ (80 mM)-induced contrac-
tions
Effect of Tp.Cr on K+ (80 mM)-induced con-
tractions is given in Figures 2-4. The possible mech-
anism of the observed relaxant activity of the Tp.Cr
on the isolated rabbit jejunum preparations was
speculated to be mediated through calcium channels
blockade and the idea was tested through application
of the crude plant extract on high K+ (80 mM)-
induced sustained contractions in the isolated rabbit
jejunum preparations. The isolated rabbit jejunum
preparations on exposure to high K+ (80 mM) pro-
duced a sustained contraction by depolarization of
the tissues. The Tp.Cr on addition to tissue bath in
cumulative manner demonstrated a complete relax-
ation of K+ (80 mM)-induced contractions in a tissue
bath concentration dependent manner at a concen-
tration range of 0.003-1 mg/mL with EC50 value of
0.325 mg/mL (95% CI; 0.2877-0.3688), whereas,
the standard drug, verapamil, showed complete
relaxation of K+ (80 mM)-induced contractions at a
tissue bath concentration range of 0.0003-0.3 µM,
with EC50 value of 0.114 µM (95% CI; 0.09841-
0.1315). Verapamil showed complete relaxation of
K+ (80 mM)-induced contractions at a tissue bath
concentration of 0.3 µM.
Effect of Tp.Cr on isolated rabbit tracheal prepa-
rations
Tp.Cr on application to the isolated rabbit tra-
cheal preparations in cumulative manner exhibited a
concentration dependent relaxant effect in the con-
centration range of 0.003-3 mg/mL for carbachol-
induced contractions and 0.003-1 mg/mL for K+ (80
mM)-induced contractions. The EC50 value for car-
bachol-induced contraction was 0.6499 mg/mL
(95% CI; 0.4719-0.8953) and EC50 value for K+ (80
mM)-induced contractions was 0.2638 mg/mL (95%
CI; 0.2199-0.3238) (Fig. 6a, 7a), whereas verapamil
showed relaxant effect on carbachol-induced con-
traction in the tissue bath concentration range of
0.0001-0.3 µM with EC50 value of 0.7002 µM (95%
CI; 0.6208-0.7899) and K+ (80 mM)-induced con-
tractions in the concentration range of 0.0001-0.1
µM with EC50 value of 0.03689 µM (95% CI;
0.03326-0.04092) (Fig. 6b, 7b).
Effect of Tp.Cr on isolated guinea-pig tracheal
preparations
Tp.Cr exhibited the relaxant effect on the car-
bachol- and K+ (80 mM)-induced contractions in iso-
lated guinea-pig tracheal preparations with EC50
Figure 7. Effect of Tp.Cr on (a) carbachol (1 µM) and (b) K+ (80 mM)-induced contractions in isolated rabbit tracheal preparations
Figure 8. Effect of Tp.Cr on carbachol (1 µM) and K+ (80 mM)-
induced contractions in isolated guinea-pig tracheal preparations.
Values are expressed as the mean ± SEM, n = 5
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value of 0.2794 mg/mL (95% CI; 0. 2413-0.3236)
and 0.2182 mg/mL (95% CI;0. 1900-0.2506),
respectively (Fig. 8).
Effect of Tp.Cr on isolated rabbit aorta prepara-
tions
Tp.Cr on application to isolated rabbit aorta
preparations exhibited a dose dependent relaxant
effect on phenylephrine (1 µM) and K+ (80 mM)-
induced contractions and EC50 of 4.459 mg/mL
(95% CI; 4.208-4.725) and 1.642 mg/mL (95% CI;
1.276-2.114), respectively (Fig. 9a), whereas vera-
pamil on application to the phenylephrine (1 µM)
and K+ (80 mM)-induced contractions in the isolated
rabbit aortic preparations showed relaxant effect in
the concentration range of 0.003-10 µM with EC50
value of 3.509 µM (95% CI; 3.387ñ3.636) and at
concentration range of 0.003-5 µM with EC50 value
of 1.331 µM (95% CI; 1.113-1.592), respectively
(Fig. 9b). 
The pretreatment of isolated rabbit aortic
preparations with Tp.Cr caused a concentration
dependent (0.1-1 mg/mL) rightward shift of Ca2+
concentration response curve, similar to verapamil
with dose range 0.03-0.3 µM, thus confirming that
observed relaxant effect of Tp.Cr was likely to be
mediated through calcium channel blocking effect
(Fig, 10a, b).
Figure 9. Effect of (a) Tp.Cr and (b) verapamil on phenylephrine
and K+ (80 mM)-induced contractions in isolated rabbit aortic
preparations. Values shown are the mean ± SEM, n = 5
Figure 10. Effect of (a) Tp.Cr and (b) verapamil on concentration
response curves of Ca2+ in isolated rabbit aorta preparations.
Values shown are the mean ± SEM, n = 5
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CONCLUSIONS
The methanolic extract of the whole plant of
Tephrosia pupurea, Linn. on application to sponta-
neous contractions in isolated rabbit jejunum prepa-
rations, exerted a concentration dependent (0.003-
3.0 mg/mL) relaxant effect. The extract also caused
concentration dependent relaxation of K+ (80 mM)-
induced spastic contractions. These findings were
further supported by the observations that the extract
caused a concentration dependent rightward shift of
the Ca2+ response curves in manner similar to that of
verapamil. The extract exhibited a relaxant effect on
carbachol and high K+ (80 mM)-induced contrac-
tions of isolated rabbit tracheal preparations in a
manner similar to verapamil. The observed non-spe-
cific bronchodilator response is possibly mediated
through Ca2+ channel blockade. Moreover, the
extract also exhibited a dose dependent relaxant
effect on phenylephrine (1 µM) and K+ (80 mM)-
induced contractions in a manner similar to vera-
pamil. On the basis of the above-mentioned find-
ings, it can be concluded that the use of Tephrosia
pupurea, in gastrointestinal spasm, asthma and
hypertension is likely to be mediated through calci-
um channel blockage.
REFERENCES
1. Khare C.P.: Indian Medicinal Plants, p. 650,
Springer-Verlag, Berlin, Heidelberg 2007.
2. Balandrin, M.F., Kjocke A.J., Wurtele E.S.,
Bollinger W.H.: Science, 228, 1154 (1985).
3. Bhandari, M.M. Flora of the Indian desert. pp.
118-123, MPS Repros, Jodhpur, 1990.
4. Bishop M.: Hawaiian Ethnobotany Online
Database (2007).
5. Arnold M.D., Harry L.: Poisonous Plants of
Hawaii. Charles E. Tuttle Co., Tokyo 1968.
6. Chang L.C., Gerh‰user C., Song L., Farnsworth
N.R., Pezzuto J.M. et al.: J. Nat. Prod. 60, 869
(1997).
7. Duke J.A.: Handbook of phytochemical con-
stituents of GRASH herbs and other economic
plants, CRC Press, Tokyo 1992.
8. Qadir M.I., Malik S.A.: Rev. Med. Virol. 20, 23
(2010).
9. Qadir M.I., Malik S.A.: AIDS Res. Hum.
Retroviruses 27, 57 (2011).
10. Parjapati N.D., Purohit S.S., Sharma A.K.,
Kumar T.: A Handbook of Medicinal Plants: A
Complete Source Book, p. 506, Agrobios
(India), Jodhpur 2003.
11. Williamson E.M., Okpako D.T., Evans F.J.:
Selection, Preparation and Pharmacological
Evaluation of Plant Material, John Wiley &
Sons, Chichester 1998. 
12. Tona L., Kambu K., Ngimbi N., Vlitinck A.J.: J.
Ethnopharmacol. 61, 57 (1998). 
13. Gilani A.H., Ghayur M.N., Khalid A., Haq Z.,
Choudhary M.I. et al.: Planta Med. 71, 1 (2005).
14. Farre A.J., Colombo M., Fort M., Gutierrez B.:
Gen. Pharmacol. 22, 177 (1991).
15. Gilani A.H., Aftab K.: Arch. Pharm. Res. 15, 95
(1992).
16. Van Rossum J.M.: Arch. Int. Pharmacodyn.
Ther. 143, 299 (1963).
17. Downie J.W., Twiddy D.A., Awad S.A.: J.
Pharmacol. Exp. Ther. 3, 662 (1977).
Received: 29. 09. 2011
